192 related articles for article (PubMed ID: 17885952)
21. Differences in virulence between isolates of feline Sporotrichosis.
Nobre Mde O; Antunes Tde A; de Faria RO; Cleff MB; Fernandes CG; Muschner AC; Meireles MC; Ferreiro L
Mycopathologia; 2005 Aug; 160(1):43-9. PubMed ID: 16160768
[TBL] [Abstract][Full Text] [Related]
22. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
Fernández-Silva F; Capilla J; Mayayo E; Guarro J
Mycoses; 2014 Feb; 57(2):121-4. PubMed ID: 23879298
[TBL] [Abstract][Full Text] [Related]
23. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection.
Romo-Lozano Y; Hernández-Hernández F; Salinas E
Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186
[TBL] [Abstract][Full Text] [Related]
24. Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.
Fernandes KS; Neto EH; Brito MM; Silva JS; Cunha FQ; Barja-Fidalgo C
Immunology; 2008 Apr; 123(4):469-79. PubMed ID: 18194265
[TBL] [Abstract][Full Text] [Related]
25. Isolation of Sporothrix schenckii in the soil in Israel in relation to a new case in man.
Feuerman EJ; Alteras I; Bashan D; Lehrer NB
Sabouraudia; 1976 Jul; 14(2):217-22. PubMed ID: 959947
[TBL] [Abstract][Full Text] [Related]
26. Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study.
Mehta KI; Sharma NL; Kanga AK; Mahajan VK; Ranjan N
Mycoses; 2007 Nov; 50(6):496-501. PubMed ID: 17944713
[TBL] [Abstract][Full Text] [Related]
27. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii.
Maia DC; Sassá MF; Placeres MC; Carlos IZ
Mycopathologia; 2006 Jan; 161(1):11-9. PubMed ID: 16389479
[TBL] [Abstract][Full Text] [Related]
28. Variation in genotype and higher virulence of a strain of Sporothrix schenckii causing disseminated cutaneous sporotrichosis.
Zhang Z; Liu X; Lv X; Lin J
Mycopathologia; 2011 Dec; 172(6):439-46. PubMed ID: 21717135
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii.
Oliveira AH; de Oliveira GG; Carnevale Neto F; Portuondo DF; Batista-Duharte A; Carlos IZ
J Ethnopharmacol; 2017 Jan; 195():266-274. PubMed ID: 27856302
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex.
Almeida-Paes R; de Oliveira LC; Oliveira MM; Gutierrez-Galhardo MC; Nosanchuk JD; Zancopé-Oliveira RM
Biomed Res Int; 2015; 2015():212308. PubMed ID: 25961005
[TBL] [Abstract][Full Text] [Related]
31. Sporothrix brasiliensis produces the highest levels of oxidative stress in a murine model among the species of the Sporothrix schenckii complex.
Mario DN; Schaffer LF; Peroza LR; Jesus FPK; Denardi LB; Fachinetto R; Alves SH
Rev Soc Bras Med Trop; 2017; 50(4):554-557. PubMed ID: 28954081
[TBL] [Abstract][Full Text] [Related]
32. Antibodies Against Sporothrix schenckii Enhance TNF-α Production and Killing by Macrophages.
Franco Dde L; Nascimento RC; Ferreira KS; Almeida SR
Scand J Immunol; 2012 Feb; 75(2):142-6. PubMed ID: 21923739
[TBL] [Abstract][Full Text] [Related]
33. Tregs in the immune response of BALB/c mice experimentally infected with species of the
Corrêa-Moreira D; De Luca PM; Romeo O; C Menezes R; Paes RA; Oliveira RZ; de Moraes AM; de L Neto RG; Moraes Borba C; E de Oliveira MM
Future Microbiol; 2020 Sep; 15():1217-1225. PubMed ID: 33026880
[No Abstract] [Full Text] [Related]
34. Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?
Morgado FN; Schubach AO; Pimentel MI; Lyra MR; Vasconcellos ÉC; Valete-Rosalino CM; Conceição-Silva F
PLoS One; 2016; 11(9):e0162764. PubMed ID: 27622513
[TBL] [Abstract][Full Text] [Related]
35. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii.
Teixeira PAC; de Castro RA; Nascimento RC; Tronchin G; Pérez Torres A; Lazéra M; de Almeida SR; Bouchara JP; Loureiro Y Penha CV; Lopes-Bezerra LM
Microbiology (Reading); 2009 Nov; 155(Pt 11):3730-3738. PubMed ID: 19762444
[TBL] [Abstract][Full Text] [Related]
36. Role of melanin in the pathogenesis of cutaneous sporotrichosis.
Madrid IM; Xavier MO; Mattei AS; Fernandes CG; Guim TN; Santin R; Schuch LF; Nobre Mde O; Araújo Meireles MC
Microbes Infect; 2010 Feb; 12(2):162-5. PubMed ID: 19883789
[TBL] [Abstract][Full Text] [Related]
37. Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease.
Kajiwara H; Saito M; Ohga S; Uenotsuchi T; Yoshida S
Infect Immun; 2004 Sep; 72(9):5073-9. PubMed ID: 15322000
[TBL] [Abstract][Full Text] [Related]
38. Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates.
Castro RA; Kubitschek-Barreira PH; Teixeira PA; Sanches GF; Teixeira MM; Quintella LP; Almeida SR; Costa RO; Camargo ZP; Felipe MS; de Souza W; Lopes-Bezerra LM
PLoS One; 2013; 8(10):e75656. PubMed ID: 24116065
[TBL] [Abstract][Full Text] [Related]
39. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
[TBL] [Abstract][Full Text] [Related]
40. Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii.
Carlos IZ; Sgarbi DB; Placeres MC
Mycopathologia; 1998-1999; 144(1):9-14. PubMed ID: 10422268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
